Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacokinetic and Pharmacodynamics of YG1699 in Patients With Diabetes and Kidney Dysfunction

NCT06648876 is registered in ClinicalTrials.gov with RenJi Hospital as lead sponsor.

NCT NCT06648876
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06648876 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacokinetic and Pharmacodynamics of YG1699 in Patients With Diabetes and Kidney Dysfunction
Lead sponsor
RenJi Hospital
Phase
Phase 1
Overall status
Not yet recruiting
Start date
October 31, 2024
Completion date
October 30, 2025
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, hemodialysis, renal insufficiency, chronic